» Articles » PMID: 33992888

PAMAM Dendrimer As a Talented Multifunctional Biomimetic Nanocarrier for Cancer Diagnosis and Therapy

Overview
Publisher Elsevier
Specialty Chemistry
Date 2021 May 16
PMID 33992888
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Poly(amidoamine) dendrimers (PAMAM) are novel polymeric highly branched architectures with well-defined nano-size, narrow polydispersity index and numerous active amine functional groups at the periphery. The highly attractive feature of modifiable multiple surface functionalities facilitates conjugation of various ligands for cancer targeting, imaging and therapy. As well as, solubilization, high drug encapsulation, inherent passive targeting ability will also contribute to the therapeutic success of dendrimers. Cancer researchers are very eager about the utility of PAMAM dendrimer as a drug carrier and non-viral gene vector. This review highlighted the potential of non-targeted and ligand targeted surface engineered PAMAM dendrimers for the delivery of anticancer drugs and gene therapeutics and briefly focus on the diagnostic imaging applications of PAMAM dendrimers.

Citing Articles

Engineered mitochondria in diseases: mechanisms, strategies, and applications.

Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y Signal Transduct Target Ther. 2025; 10(1):71.

PMID: 40025039 PMC: 11873319. DOI: 10.1038/s41392-024-02081-y.


Deuterated Nanopolymers for Renal and Lymphatic Imaging via Quantitative Deuterium MRI.

Fries L, Montrazi E, Allouche-Arnon H, Opazo F, Bar-Shir A, Frydman L Nano Lett. 2025; 25(5):1758-1764.

PMID: 39841010 PMC: 11803745. DOI: 10.1021/acs.nanolett.4c03036.


Comparative Study of Functionalized Carbosilane Dendrimers for siRNA Delivery: Synthesis, Cytotoxicity, and Biophysical Properties.

Mullerova M, Tarach P, Strasak T, Curinova P, Petrickovic R, Zavodna T ACS Omega. 2025; 10(1):1047-1060.

PMID: 39829590 PMC: 11740622. DOI: 10.1021/acsomega.4c08314.


A Modular Approach to Obtain HER2-Targeting DM1-Loaded Nanoparticles for Gastric Cancer Therapy.

Zhang H, Guo L, Li X, Liu H, Zhao Z, Ji G ACS Omega. 2024; 9(49):48598-48606.

PMID: 39676924 PMC: 11635515. DOI: 10.1021/acsomega.4c07442.


Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Kesharwani P, Halwai K, Jha S, Mughram M, Salman Almujri S, Almalki W Mol Cancer. 2024; 23(1):244.

PMID: 39482651 PMC: 11526716. DOI: 10.1186/s12943-024-02163-z.